BDBM277080 US10072003, Example 1-2A::US10072003, Example 1-2B

SMILES NC(=O)c1cc(-c2ccc(F)cc2)c2CCN(C[C@H]3CCO[C@H](C3)C3CC3)Cc2n1.NC(=O)c1cc(-c2ccc(F)cc2)c2CCN(C[C@@H]3CCO[C@@H](C3)C3CC3)Cc2n1

InChI Key InChIKey=HUAYKSHJVWQNPG-MHTATLLNSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 277080   

TargetMetabotropic glutamate receptor 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM277080(US10072003, Example 1-2A | US10072003, Example 1-2...)
Affinity DataIC50:  1.29E+5nMAssay Description:The utility of the compounds of the invention as antagonists of metabotropic glutamate receptor activity, in particular mGluR2 activity, may be demon...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMetabotropic glutamate receptor 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM277080(US10072003, Example 1-2A | US10072003, Example 1-2...)
Affinity DataIC50:  1.29E+5nMAssay Description:The utility of the compounds of the invention as antagonists of metabotropic glutamate receptor activity, in particular mGluR2 activity, may be demon...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent